Converge Bio is a pioneering company that integrates Generative AI with biological data to revolutionize drug discovery and development. By leveraging Large Language Models (LLMs) trained on the unique syntax of biological systems, Converge enables biotech and pharmaceutical companies to predict biological outcomes, gain deeper insights, and generate novel molecular candidates. This approach enhances the understanding of complex molecular interactions, signaling pathways, and disease mechanisms, facilitating the identification of promising drug candidates.